title: The potential clinical applications and prospects of microRNAs in lung cancer.
abstract: Lung cancer is the major cause of cancer deaths worldwide due to its late diagnosis and poor outcome. Understanding genomic medicine may widen our vision into the oncogenesis of lung cancer and may open the door to improvements in the clinical management of lung cancer. It is well known that almost half of all genes are regulated by microRNAs (miRNAs). This review focuses on the role of miRNAs in lung cancer and also touches on the value of miRNA-based novel therapies for lung cancers.
authors.affiliation: Department of Radiotherapy Oncology, First Affiliated Hospital of Medical College of Xi'an Jiaotong University, China.
authors.forename: Ying
authors.initials: Y
authors.lastname: Gao
authors.affiliation: Department of Neurology, First Affiliated Hospital of Xi'an Medical University, Xi'an, People's Republic of China.
authors.forename: Fei
authors.initials: F
authors.lastname: Gao
authors.affiliation: Department of Radiotherapy Oncology, First Affiliated Hospital of Medical College of Xi'an Jiaotong University, China.
authors.forename: Jin-Lu
authors.initials: JL
authors.lastname: Ma
authors.affiliation: Department of Radiotherapy Oncology, First Affiliated Hospital of Medical College of Xi'an Jiaotong University, China.
authors.forename: Wen-Ze
authors.initials: WZ
authors.lastname: Sun
authors.affiliation: Department of Radiotherapy Oncology, First Affiliated Hospital of Medical College of Xi'an Jiaotong University, China.
authors.forename: Li-Ping
authors.initials: LP
authors.lastname: Song
keywords: biomarker; chemotherapy; lung cancer; microRNA; radiotherapy